Get Help Sign In
ProcessingProcessing

CRISPR genome editing

Navigating the regulatory landscape: A business perspective on cell and gene therapy approvals

The development of cell and gene therapies (CGT) hold great promise for treating previously untreatable conditions, but navigating the approval process presents a significant challenge. This article outlines the complex steps involved, from initial discovery to FDA review, and emphasizes the importance of strategic partnerships to ensure these innovative therapies reach patients safely and effectively.